• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Splitomicin

Splitomicin

Product ID S6247
Cas No. 5690-03-9
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $68.30 In stock
10 mg $126.00 In stock
25 mg $262.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Splitomicin is a cell-permeable lactone that acts as an inhibitor of sirtuins 1 and 2 (SIRT1, SIRT2); sirtuins are considered class III histone deacetylases (HDACs). Splitomicin displays anti-inflammatory, antioxidative, and antithrombotic activities. In vitro, splitomicin promotes translocation of FOXO3a, decreasing cell motility and enhancing activity of paclitaxel. In neutrophils, splitomicin decreases production of superoxide anions, suppresses activation of ERK, and increases levels of cAMP. In other cellular models, this compound inhibits thrombin-induced platelet aggregation, preventing increases in thromboxane B2 (TxB2) and release of intracellular Ca2+; this compound may also inhibit phosphodiesterases. Splitomicin also alters RNA splicing activity.

Product Info

Cas No.

5690-03-9

Purity

≥98%

Formula

C13H10O2

Formula Wt.

198.22

IUPAC Name

1,2-dihydrobenzo[f]chromen-3-one

Appearance

White Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

S6247 MSDS PDF

Info Sheet

S6247 Info Sheet PDF

References

Hori YS, Kuno A, Hosoda R, et al. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS One. 2013 Sep 11;8(9):e73875. PMID: 24040102.

Bonezzi K, Belotti D, North BJ, et al. Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies. Neoplasia. 2012 Sep;14(9):846-54. PMID: 23019416.

Liu FC, Day YJ, Liou JT, et al. Splitomicin inhibits fMLP-induced superoxide anion production in human neutrophils by activate cAMP/PKA signaling inhibition of ERK pathway. Eur J Pharmacol. 2012 Aug 5;688(1-3):68-75. PMID: 22634165.

Liu FC, Liao CH, Chang YW, et al. Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release. Thromb Res. 2009 Jun;124(2):199-207. PMID: 19327818.

Kuhn AN, van Santen MA, Schwienhorst A, et al. Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation. RNA. 2009 Jan;15(1):153-75. PMID: 19029308.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G3357

    Ginkgolide C

    Diterpene lactone found in Ginkgo; GABA-A, α-1...

    ≥98%
  • T1676

    L-Tetrahydropalmatine

    Alkaloid found in Corydalis and Stephania; D1/2...

    ≥98%
  • C3578

    L-Citrulline

    Byproduct of L-arginine metabolism found in wat...

    ≥98%
  • G7242

    GSK-690693

    Akt inhibitor.

    ≥99%
  • S0032

    Saikosaponin B1

    Saponin found in Bupleurum, Heteromorpha, and S...

    ≥98%
  • E0001

    E64

    Cysteine protease inhibitor.

    ≥99%
  • U5233

    Universal Tetanus Toxin Epitope P2 (830-844)

    Peptide, tetanus toxin epitope.

    ≥95%
  • L1884

    Levosimendan

    Ca2+ sensitizer; ATP-sensitive K+ channel activ...

    ≥98%
  • N3448

    Nimodipine

    L-type Ca2+ channel blocker.

    ≥98%
  • P004080

    PAC-1

    Zinc chelator

    ≥98%
  • V0160

    Vapreotide

    Synthetic somatostatin analog, peptide; somatos...

    ≥95%
  • C179604

    CEP-28122 Mesylate

    ALK inhibitor.

    ≥98%
  • A4805

    Amastatin Hydrochloride Hydrate

    Aminopeptidase inhibitor.

    ≥98%
  • C4517

    Clenbuterol Hydrochloride

    β2-adrenergic agonist.

    ≥98%
  • L186858

    Levomefolic acid

    Folic acid derivative

    ≥98%
  • L8261

    Lupeol

    Triterpene; potential tyrosinase inhibitor.

    ≥98%
  • F4780

    Fluoxetine Hydrochloride

    FIASMA, SERT inhibitor, 5-HT and σ1 antagonist...

    ≥98%
  • A6132

    Apicidin

    Cyclic tetrapeptide; HDAC inhibitor.

    ≥98%
  • S680000

    SR144528

    Selective cannabinoid receptor 2 (CB2) inverse ...

    ≥98%
  • R2710

    Recombinant Multi-epitope Chimeric HCV Antigen

    Recombinant Multi-epitope Chimeric HCV antigen....

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only